DEPARTMENT OF HEALTH AND HUMAN SERVICES 
PUBLIC HEALTH SERVICE 
NATIONAL INSTITUTES OF HEALTH 
RECOMBINANT DNA ADVISORY COMMITTEE 
MINUTES OF MEETING 1 
June 7-8, 1993 
The Recombinant DNA Advisory Committee (RAC) was convened for its fifty-fourth 
meeting at 9:00 a.m. on June 7, 1993, at the National Institutes of Health (NIH), 
Building 31, Conference Room 6, 9000 Rockville Pike, Bethesda, Maryland 20892. Dr. 
LeRoy B. Walters (Chair) presided. In accordance with Public Law 92-463, the meeting 
was open to the public except for the closed session to discuss the expedited approval of 
a human gene transfer protocol submitted by Drs. Ivor Royston and Robert Sobol which 
included confidential information. The following were present for all or part of the 
meeting: 
Committee members: 
Constance E. Brinckerhoff, Dartmouth Medical School 
Alexander M. Capron, University of Southern California 
Ira H. Carmen, University of Illinois 
Gary A. Chase, Johns Hopkins University 
Patricia A. DeLeon, University of Delaware 
Roy H. Doi, University of California, Davis 
Krishna R. Dronamraju, Foundation for Genetic Research 
E. Peter Geiduschek, University of California, San Diego 
Mariann Grossman, Hospital of the University of Pennsylvania 
Robert Haselkorn, University of Chicago 
Susan S. Hirano, University of Wisconsin 
Donald J. Krogstad, Tulane University School of Medicine 
Brigid G. Leventhal, Johns Hopkins Hospital 
Abbey S. Meyers, National Organization for Rare Disorders 
A. Dusty Miller, Fred Hutchinson Cancer Research Center 
Arno G. Motulsky, University of Washington Medical School 
Robertson Parkman, Childrens Hospital of Los Angeles 
Leonard E. Post, Parke-Davis Pharmaceutical Division 
Marian G. Secundy, Howard University College of Medicine 
Brian R. Smith, Yale University School of Medicine 
lr The RAC is advisory to the National Institutes of Health (NIH), and its 
recommendations should not be considered as final or accepted. The Office of 
Recombinant DNA Activities should be consulted for NIH policy on specific issues. 
Recombinant DNA Research, Volume 17 
[543] 
